Regulus Therapeutics Inc Cash Flow Reinvestment Rate
Regulus Therapeutics Inc cash flow reinvestment rate. Regulus Therapeutics Inc (RGLS) has a Cash Flow Reinvestment Rate of 0.07x as of December 2020, reinvesting $237.00K (capex $237.00K ) from operating cash flow of $3.19 Million. Explore cash flow to debt ratio of Regulus Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Regulus Therapeutics Inc (2010–2010)
Cash flow reinvestment rate of Regulus Therapeutics Inc from 2010 to 2010. Historical reinvestment intensity for Regulus Therapeutics Inc across 1 annual periods. Explore how much does Regulus Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Regulus Therapeutics Inc Cash Flow Reinvestment Rate by Year (2010–2010)
Regulus Therapeutics Inc cash flow reinvestment rate by year from 2010 to 2010. Year-by-year capital reinvestment analysis for Regulus Therapeutics Inc. For the full cash flow conversion analysis, see Regulus Therapeutics Inc (RGLS) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.20x | $2.42 Million | $12.31 Million | $2.42 Million | — |